Cancer stem cells have an “energy addiction” scientists may be able to exploit
Researchers found that high-risk MDS stem cells rely heavily on a molecule called NAD to function, more so than healthy blood-forming cells. This energy pathway can be selectively disrupted, potentially weakening cancer-driving cells. Scientists may be able to exploit this weakness to develop new treatments.
Why it's good news: It opens up a potential new target for treatment of high-risk MDS stem cells, offering hope for better outcomes for patients affected by these aggressive cancers.
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
The morning letter delivers the day's best positive headlines before the rest of the internet gets loud. Free, no tracking, one click to leave.
Get the morning letter →
Scientists have discovered an enzyme that could help stop fatty liver disease from progressing. This enzyme, UBE2N, help…
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →